{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:41:58Z","timestamp":1791729718868,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010898","name":"Edinburgh and Lothians Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office","doi-asserted-by":"publisher","award":["TCS\/20\/11"],"award-info":[{"award-number":["TCS\/20\/11"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.clon.2025.103807","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:09:37Z","timestamp":1742404177000},"page":"103807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prognostic Implications of HPV Cell-Free DNA Serial Testing During Follow-Up of p16 Positive Oropharyngeal Squamous Cell Carcinoma After Curative-Intent Treatment"],"prefix":"10.1016","volume":"41","author":[{"given":"V.","family":"Salati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9957-4439","authenticated-orcid":false,"given":"M.","family":"Adamowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4227-0467","authenticated-orcid":false,"given":"L.","family":"McKean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6738-2152","authenticated-orcid":false,"given":"D.","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3213-7103","authenticated-orcid":false,"given":"J.","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7984-8431","authenticated-orcid":false,"given":"S.","family":"Linton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4911-1532","authenticated-orcid":false,"given":"C.","family":"Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6033-1341","authenticated-orcid":false,"given":"C.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2604-3928","authenticated-orcid":false,"given":"K.","family":"Cuschieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7847-9355","authenticated-orcid":false,"given":"B.","family":"Conn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-836X","authenticated-orcid":false,"given":"A.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7875-4502","authenticated-orcid":false,"given":"T.J.","family":"Aitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8919-8783","authenticated-orcid":false,"given":"I.J.","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clon.2025.103807_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1473-3099(18)30802-8","article-title":"Gender-neutral HPV vaccination in the UK, rising male oropharyngeal cancer rates, and lack of HPV awareness","volume":"19","author":"Lechner","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.clon.2025.103807_bib2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"22","key":"10.1016\/j.clon.2025.103807_bib3","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1158\/0008-5472.CAN-16-0633","article-title":"HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology","volume":"76","author":"Schache","year":"2016","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.clon.2025.103807_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/v13071326","article-title":"A\u00a0Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide","volume":"13","author":"Carlander","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.clon.2025.103807_bib5","article-title":"Current perspectives on recurrent HPV-mediated oropharyngeal cancer","volume":"12","author":"Guo","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103807_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.clon.2025.103807_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40463-018-0302-y","article-title":"The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review","volume":"47","author":"Liu","year":"2018","journal-title":"J\u00a0Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clon.2025.103807_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.oraloncology.2019.08.011","article-title":"12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers","volume":"97","author":"Rulach","year":"2019","journal-title":"Oral Oncol"},{"issue":"27","key":"10.1016\/j.clon.2025.103807_bib9","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1200\/JCO.2013.53.5633","article-title":"Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522","volume":"32","author":"Ang","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103807_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.oraloncology.2012.07.015","article-title":"Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer","volume":"49","author":"Huang","year":"2013","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.clon.2025.103807_bib11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2012.44.0164","article-title":"Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis","volume":"31","author":"O'Sullivan","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2025.103807_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/jamaoto.2015.136","article-title":"Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy","volume":"141","author":"Trosman","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.clon.2025.103807_bib13","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.3390\/curroncol28030156","article-title":"Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options","volume":"28","author":"Modesto","year":"2021","journal-title":"Curr Oncol"},{"issue":"11","key":"10.1016\/j.clon.2025.103807_bib14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jmoldx.2020.08.002","article-title":"Plasma Cell-Free Human Papillomavirus Oncogene E6 and E7 DNA Predicts Outcome in Oropharyngeal Squamous Cell Carcinoma","volume":"22","author":"Reder","year":"2020","journal-title":"J\u00a0Mol Diagn"},{"issue":"1","key":"10.1016\/j.clon.2025.103807_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13073-019-0634-x","article-title":"Designing circulating tumor DNA-based interventional clinical trials in oncology","volume":"11","author":"Araujo","year":"2019","journal-title":"Genome Med"},{"issue":"15","key":"10.1016\/j.clon.2025.103807_bib16","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1158\/1078-0432.CCR-19-0211","article-title":"Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer","volume":"25","author":"Chera","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.clon.2025.103807_bib17","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1093\/annonc\/mdy251","article-title":"Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer","volume":"29","author":"Hanna","year":"2018","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.clon.2025.103807_bib18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/bjc.2017.258","article-title":"Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma","volume":"117","author":"Lee","year":"2017","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.clon.2025.103807_bib19","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/hed.27515","article-title":"It is time to improve the diagnostic workup of oropharyngeal cancer with circulating tumor HPV DNA: Systematic review and meta-analysis","volume":"45","author":"Paolini","year":"2023","journal-title":"Head Neck"},{"issue":"10","key":"10.1016\/j.clon.2025.103807_bib20","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.19.02444","article-title":"Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer","volume":"38","author":"Chera","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"19","key":"10.1016\/j.clon.2025.103807_bib21","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1002\/cncr.29538","article-title":"Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer","volume":"121","author":"Dahlstrom","year":"2015","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.clon.2025.103807_bib22","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.ejso.2022.03.232","article-title":"Longitudinal measurement of HPV copy number in cell-free DNA is associated with patient outcomes in HPV-positive oropharyngeal cancer","volume":"48","author":"Warlow","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103807_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejso.2022.09.016","article-title":"The role of liquid biopsy in management of the neck with indeterminate response on post-treatment imaging following non-surgical management of oropharyngeal cancer","volume":"49","author":"Li","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"16_suppl","key":"10.1016\/j.clon.2025.103807_bib24","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1200\/JCO.2022.40.16_suppl.6006","article-title":"Association of plasma tumor tissue modified viral HPV DNA (TTMV) with tumor burden, treatment type, and outcome: A translational analysis from NRG-HN002","volume":"40","author":"Yom","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103807_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13063-023-07881-1","article-title":"CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer","volume":"25","author":"Mehanna","year":"2024","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.clon.2025.103807_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines","volume":"110","author":"Gregoire","year":"2014","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103807_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","article-title":"International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma","volume":"126","author":"Lee","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103807_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gregoire","year":"2018","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.clon.2025.103807_bib29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2217\/fon-2018-0405","article-title":"JAVELIN Head and Neck 100: a Phase III trial of avelumab and chemoradiation for locally advanced head and neck cancer","volume":"15","author":"Yu","year":"2019","journal-title":"Future Oncol"},{"issue":"10","key":"10.1016\/j.clon.2025.103807_bib30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamaoto.2019.1934","article-title":"Association of NCCN-Recommended Posttreatment Surveillance With Outcomes in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma","volume":"145","author":"Masroor","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clon.2025.103807_bib31","unstructured":"\u2018Guidelines Detail\u2019, NCCN. Accessed: Jul. 07, 2024. [Online]. Available: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1437."},{"issue":"5","key":"10.1016\/j.clon.2025.103807_bib32","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijrobp.2013.08.049","article-title":"Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status","volume":"87","author":"Huang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"25","key":"10.1016\/j.clon.2025.103807_bib33","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial","volume":"38","author":"Palma","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2025.103807_bib34","unstructured":"Study Details Blood-Based Biomarkers to Inform Treatment and Radiation Therapy Decisions for HPV Associated Oropharyngeal Squamous Cell Head and Neck Cancers ClinicalTrials.gov. Accessed: Nov. 19, 2023. [Online]. Available: https:\/\/www.clinicaltrials.gov\/study\/NCT05541016."},{"key":"10.1016\/j.clon.2025.103807_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejca.2018.08.015","article-title":"Human papillomavirus-associated oropharyngeal cancer among patients aged 70 and older: Dramatically increased prevalence and clinical implications","volume":"103","author":"Lu","year":"2018","journal-title":"Eur J Cancer"},{"issue":"18","key":"10.1016\/j.clon.2025.103807_bib36","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1200\/JCO.19.00370","article-title":"Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals","volume":"37","author":"Tota","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2025.103807_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.oraloncology.2018.06.013","article-title":"Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database","volume":"83","author":"Rettig","year":"2018","journal-title":"Oral Oncol"},{"issue":"8","key":"10.1016\/j.clon.2025.103807_bib38","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1007\/s00405-023-07952-8","article-title":"Post-therapeutic surveillance of HPV-driven oropharyngeal cancers: are we ready to change our practices?","volume":"280","author":"Mirghani","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655525000627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655525000627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:35:46Z","timestamp":1762331746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655525000627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":38,"alternative-id":["S0936655525000627"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2025.103807","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Implications of HPV Cell-Free DNA Serial Testing During Follow-Up of p16 Positive Oropharyngeal Squamous Cell Carcinoma After Curative-Intent Treatment","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2025.103807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"103807"}}